STOCK TITAN

ACORDA THERAPEUTICS INC - $ACORQ STOCK NEWS

Welcome to our dedicated page for ACORDA THERAPEUTICS news (Ticker: $ACORQ), a resource for investors and traders seeking the latest updates and insights on ACORDA THERAPEUTICS stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ACORDA THERAPEUTICS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ACORDA THERAPEUTICS's position in the market.

Rhea-AI Summary
Acorda Therapeutics faces delisting from Nasdaq due to non-compliance with listing rules and Chapter 11 proceedings, now trading on OTC Pink under 'ACORQ' ticker symbol.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5%
Tags
none
ACORDA THERAPEUTICS INC

Nasdaq:ACORQ

ACORQ Rankings

ACORQ Stock Data

472.00k
1.22M
0.69%
13.22%
0.65%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Pearl River